首页> 外文期刊>JAMA: the Journal of the American Medical Association >Use of continuous quality improvement to increase use of process measures in patients undergoing coronary artery bypass graft surgery: a randomized controlled trial.
【24h】

Use of continuous quality improvement to increase use of process measures in patients undergoing coronary artery bypass graft surgery: a randomized controlled trial.

机译:进行持续质量改善以增加在进行冠状动脉搭桥手术的患者中使用过程测量方法的随机对照试验。

获取原文
获取原文并翻译 | 示例
           

摘要

CONTEXT: A rigorous evaluation of continuous quality improvement (CQI) in medical practice has not been carried out on a national scale. OBJECTIVE: To test whether low-intensity CQI interventions can be used to speed the national adoption of 2 coronary artery bypass graft (CABG) surgery process-of-care measures: preoperative beta-blockade therapy and internal mammary artery (IMA) grafting in patients 75 years or older. DESIGN, SETTING, AND PARTICIPANTS: Three hundred fifty-nine academic and nonacademic hospitals (treating 267 917 patients using CABG surgery) participating in the Society of Thoracic Surgeons National Cardiac Database between January 2000 and July 2002 were randomized to a control arm or to 1 of 2 groups that used CQI interventions designed to increase use of the process-of-care measures. INTERVENTION: Each intervention group received measure-specific information, including a call to action to a physician leader; educational products; and periodic longitudinal, nationally benchmarked, site-specific feedback. MAIN OUTCOME MEASURE: Differential incorporation of the targeted care processes into practice at the intervention sites vs the control sites, assessed by measuring preintervention (January-December 2000)/postintervention (January 2001-July 2002) site differences and by using a hierarchical patient-level analysis. RESULTS: From January 2000 to July 2002, use of both process measures increased nationally (beta-blockade, 60.0%-65.6%; IMA grafting, 76.2%-82.8%). Use of beta-blockade increased significantly more at beta-blockade intervention sites (7.3% [SD, 12.8%]) vs control sites (3.6% [SD, 11.5%]) in the preintervention/postintervention (P =.04) and hierarchical analyses (P<.001). Use of IMA grafting also tended to increase at IMA intervention sites (8.7% [SD, 17.5%]) vs control sites (5.4% [SD,15.8%]) (P =.20 and P =.11 for preintervention/postintervention and hierarchical analyses, respectively). Both interventions tended to have more impact at lower-volume CABG sites (for interaction: P =.04 for beta-blockade; P =.02 for IMA grafting). CONCLUSIONS: A multifaceted, physician-led, low-intensity CQI effort can improve the adoption of care processes into national practice within the context of a medical specialty society infrastructure.
机译:背景:尚未在全国范围内对医学实践中的持续质量改进(CQI)进行严格评估。目的:测试低强度CQI干预措施是否可用于加快全国范围内采用两种冠状动脉搭桥术(CABG)的手术过程护理措施:术前β受体阻滞治疗和内乳动脉(IMA)移植75岁以上。设计,地点和参加者:2000年1月至2002年7月期间参加胸外科医师学会国家心脏数据库的359家学术和非学术医院(使用CABG手术治疗267 917例患者)被随机分配至对照组或1名。 2个小组使用了CQI干预措施,旨在增加对护理过程措施的使用。干预措施:每个干预组均收到针对具体措施的信息,包括呼吁医师领导采取行动;教育产品;以及定期的纵向,国家基准,针对特定地点的反馈。主要观察指标:通过测量干预前(2000年1月至2000年12月)/干预后(2001年1月至2002年7月)的现场差异并采用分级的患者-水平分析。结果:从2000年1月到2002年7月,这两种方法的使用在全国范围内有所增加(β受体阻滞剂为60.0%-65.6%; IMA接枝率为76.2%-82.8%)。在干预前/干预后(P = .04)和分级干预中,β受体阻滞干预部位(7.3%[SD,12.8%])的使用率显着高于对照部位(3.6%[SD,11.5%])。分析(P <.001)。与IMA干预部位(5.4%[SD,15.8%])相比,IMA干预部位(8.7%[SD,17.5%])使用IMA移植的趋势也有所增加(干预前/干预后P = .20和P = .11)。层次分析)。两种干预措施都倾向于在小批量CABG部位产生更大的影响(相互作用:β阻滞P = .04; IMA接枝P = .02)。结论:由医师主导,低强度的多方面CQI努力可以在医疗专业协会基础设施的背景下改善护理程序在国家实践中的采用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号